Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

[New aspects of the pathogenesis of lateral amyotrophic sclerosis].

Skvortsova VI, Bachurin SO, Razinskaia OD, Smirnov AP, Kovrazhkina EA, Pochigaeva KI, Ninkina NN, Shelkovnikova TA, Ustiugov AA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2):4-9. Russian. No abstract available.

PMID:
21510103
2.

Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.

Morello G, Cavallaro S.

Future Med Chem. 2015;7(10):1335-59. doi: 10.4155/fmc.15.60. Review.

3.

[Acetylation in disseminated sclerosis and amyotrophic lateral sclerosis].

Zavalishin IA, Kovaleva VL, Larskiĭ EG, Mzhel'skaia TI, Niiazbekova AS.

Sov Med. 1986;(9):31-4. Russian. No abstract available.

PMID:
3798218
4.

Branched-chain aminoacids in amyotrophic lateral sclerosis.

[No authors listed]

Lancet. 1988 Sep 17;2(8612):680-2. No abstract available.

PMID:
2901533
5.

[Therapy of amyotrophic lateral sclerosis].

Hartmann-von Monakow K.

Bibl Psychiatr Neurol. 1969;139:475. German. No abstract available.

PMID:
5406914
6.

[Amyotrophic lateral sclerosis, a disease with a complex diagnosis].

Catteau A, Février M, Khoumri K, Rabec C, Giroud M.

Rev Infirm. 2013 Feb;(188):14-6. French.

PMID:
23477081
7.

Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.

Bruneteau G, Simonet T, Bauché S, Mandjee N, Malfatti E, Girard E, Tanguy ML, Behin A, Khiami F, Sariali E, Hell-Remy C, Salachas F, Pradat PF, Fournier E, Lacomblez L, Koenig J, Romero NB, Fontaine B, Meininger V, Schaeffer L, Hantaï D.

Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3.

PMID:
23824486
8.

Optineurin and amyotrophic lateral sclerosis.

Maruyama H, Kawakami H.

Geriatr Gerontol Int. 2013 Jul;13(3):528-32. doi: 10.1111/ggi.12022. Epub 2012 Dec 26. Review.

PMID:
23279185
9.

Abnormal EAAT2 splicing in amyotrophic lateral sclerosis.

Collier DA.

Mol Psychiatry. 1998 Jul;3(4):298. No abstract available.

PMID:
9702736
10.

Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis.

Bergeron C.

J Neurol Sci. 1995 May;129 Suppl:81-4. Review.

PMID:
7595629
11.

Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?

Iłzecka J.

Curr Opin Investig Drugs. 2006 Jan;7(1):54-9. Review.

PMID:
16425672
12.

Another angiogenic gene linked to amyotrophic lateral sclerosis.

Lambrechts D, Lafuste P, Carmeliet P, Conway EM.

Trends Mol Med. 2006 Aug;12(8):345-7. Epub 2006 Jul 14.

PMID:
16843725
13.

Natural compounds used as therapies targeting to amyotrophic lateral sclerosis.

Nabavi SF, Daglia M, D'Antona G, Sobarzo-Sánchez E, Talas ZS, Nabavi SM.

Curr Pharm Biotechnol. 2015;16(3):211-8. Review.

PMID:
25601606
14.

RNA metabolism in relation to amyotrophic lateral sclerosis.

Engel WK.

Adv Neurol. 1991;56:125-53. Review. No abstract available.

PMID:
1713013
15.

Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials.

Mitsumoto H, Hanson MR, Chad DA.

Arch Neurol. 1988 Feb;45(2):189-202. Review.

PMID:
3277599
16.

The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis.

Fukunaga K, Shinoda Y, Tagashira H.

J Pharmacol Sci. 2015 Jan;127(1):36-41. doi: 10.1016/j.jphs.2014.12.012. Epub 2014 Dec 24. Review.

17.

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.

Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA.

Nat Genet. 2008 May;40(5):572-4. doi: 10.1038/ng.132. Epub 2008 Mar 30.

PMID:
18372902
18.

Amyotrophic lateral sclerosis, excitotoxicity and riluzole.

Obrenovitch TP.

Trends Pharmacol Sci. 1998 Jan;19(1):9-11. No abstract available.

PMID:
9509893
19.

[Amino acid metabolism in lateral amyotrophic sclerosis].

Pivovarova VM.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1971;71(8):1169-73. Russian. No abstract available.

PMID:
5136822
20.

Emerging targets and treatments in amyotrophic lateral sclerosis.

Zinman L, Cudkowicz M.

Lancet Neurol. 2011 May;10(5):481-90. doi: 10.1016/S1474-4422(11)70024-2. Review.

PMID:
21511200

Supplemental Content

Support Center